LISA FETTERS: Open Payments
NPI 1104254473 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 23 payments from 11 companies in 2025. Trend: 2023 $652 · 2024 $681 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| PFIZER INC. | 2 | $31 |
| Amgen Inc. | 2 | $30 |
| ABBVIE INC. | 2 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $15 |
Products named: Wegovy, JARDIANCE, TRELEGY ELLIPTA, AIRSUPRA, ELIQUIS, SPRAVATO, Dexcom G6 Transmitter, REPATHA.
Industry payments across VA — which companies pay providers there.
